As Washington pushes cheaper medicines through TrumpRx, Mark Cuban challenges the pharmaceutical middlemen, and big pharma pours billions into oral peptide technologies, Entera Bio ( NASDAQ:ENTX) is ...

Power distribution shouldn’t lock a facility into one layout. Here’s how engineers are designing leaner, code-compliant power ...

Buoyed by new results from a phase 1b/2a trial, Roche has said it plans to start a phase 3 programme for an Alzheimer's disease candidate from its Brainshuttle programme, a technology designed to help ...

UCB and Biogen say their first phase 3 trial of their systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, and a second is now expected to start before the end of the year.

Christian & Timbers announces the launch of CT Labs, an enterprise AI strategy consulting and delivery platform designed to help organizations move beyond pilots to governed, prod ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that a detailed analysis of the Phase III ALLEGORY trial of Gazyva ® (obinutuzumab) in adults with systemic lupus ...

Delcath Systems, Inc. (Nasdaq: DCTH), ("Delcath" or the "Company") an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the publication ...

Figure 1 - Longitudinal view of the Phase 2 extension drilling program at Berrigan Mine: 3D longitudinal section showing ...

FENhance 1 met its primary endpoint, showing investigational fenebrutinib significantly reduced relapses by 51% compared to teriflunomide in relapsing multiple sclerosis (RMS), consistent with ...

Learn more about the latest products to arrive at the Model Railroader offices for the week ending March 6th 2026.

Carlisle Development Partners is a team made up of the owners of the 700-acre Country Club Road tract, until last year ...